Therapeutic implications of targeting autophagy and TGF-β crosstalk for the treatment of liver fibrosis

S Siapoush, R Rezaei, H Alavifard, B Hatami, MR Zali… - Life Sciences, 2023 - Elsevier
Liver fibrosis is characterized by the excessive deposition and accumulation of extracellular
matrix components, mainly collagens, and occurs in response to a broad spectrum of …

The roles of epigenetic regulation and the tumor microenvironment in the mechanism of resistance to systemic therapy in hepatocellular carcinoma

K Oura, A Morishita, S Hamaya, K Fujita… - International Journal of …, 2023 - mdpi.com
Primary liver cancer is the sixth most common cancer and the third most common cause of
cancer-related deaths worldwide. Hepatocellular carcinoma (HCC) is a major histologic type …

The programmed site-specific delivery of LY3200882 and PD-L1 siRNA boosts immunotherapy for triple-negative breast cancer by remodeling tumor …

P Zhang, C Qin, N Liu, X Zhou, X Chu, F Lv, Y Gu, L Yin… - Biomaterials, 2022 - Elsevier
Despite the remarkable success of immunotherapies over the past decade, their
effectiveness against triple-negative breast cancer (TNBC) is limited to a small subset of …

USP8 positively regulates hepatocellular carcinoma tumorigenesis and confers ferroptosis resistance through β-catenin stabilization

J Tang, G Long, L **ao, L Zhou - Cell Death & Disease, 2023 - nature.com
Hepatocellular carcinoma (HCC) is the most common type of primary hepatic carcinoma,
which is a growing public health problem worldwide. One of the main genetic alterations in …

Stabilization of TGF‐β receptor 1 by a receptor‐associated adaptor dictates feedback activation of the TGF‐β signaling pathway to maintain liver cancer stemness and …

K Liu, F Tian, X Chen, B Liu, S Tian, Y Hou… - Advanced …, 2024 - Wiley Online Library
Dysregulation of the transforming growth factor‐β (TGF‐β) signaling pathway regulates
cancer stem cells (CSCs) and drug sensitivity, whereas it remains largely unknown how …

Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma

L Jiang, L Li, Y Liu, M Zhan, L Lu, S Yuan… - Frontiers in …, 2023 - frontiersin.org
Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer, and it
usually occurs following chronic liver disease. Although some progress has been made in …

Wnt/β-Catenin signaling as a driver of stemness and metabolic reprogramming in hepatocellular carcinoma

RWH Leung, TKW Lee - Cancers, 2022 - mdpi.com
Simple Summary Aberrant Wnt/β-catenin signaling has been reported to play crucial role in
pathogenesis of hepatocellular carcinoma (HCC). In this review, we focus on the regulatory …

β-Catenin signaling in hepatocellular carcinoma

C Xu, Z Xu, Y Zhang, M Evert… - The Journal of …, 2022 - Am Soc Clin Investig
Deregulated Wnt/β-catenin signaling is one of the main genetic alterations in human
hepatocellular carcinoma (HCC). Comprehensive genomic analyses have revealed that …

Carvacrol enhances anti-tumor activity and mitigates cardiotoxicity of sorafenib in thioacetamide-induced hepatocellular carcinoma model through inhibiting TRPM7

EH Yousef, NFA El-Magd, AM El Gayar - Life Sciences, 2023 - Elsevier
Abstract Aims Sorafenib (Sora) represents one of the few effective drugs for the treatment of
advanced hepatocellular carcinoma (HCC), while resistance and cardiotoxicity limit its …

A feedback loop of PPP and PI3K/AKT signal pathway drives regorafenib-resistance in HCC

H Yang, D Chen, Y Wu, H Zhou, W Diao, G Liu… - Cancer & Metabolism, 2023 - Springer
Background Hepatocellular carcinoma (HCC) is a principal type of liver cancer with high
incidence and mortality rates. Regorafenib is a novel oral multikinase inhibitor for second …